Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Memoli

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|May 2, 2024
Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patientsAinhoa Pérez-Díez, Xiangdong Liu, Stephanie Calderon, et al.
Medrxiv : the Preprint Server for Health Sciences|October 6, 2021
Pre-pandemic SARS-CoV-2 serological reactivity in rural malaria-experienced CambodiansJessica Manning, Irfan Zaidi, Chanthap Lon, et al.
Science Translational Medicine|April 14, 2017
Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus diseaseJohn C Kash, Kathie-Anne Walters, Jason Kindrachuk, et al.
Emerging Infectious Diseases|January 25, 2022
SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, CambodiaJessica Manning, Irfan Zaidi, Chanthap Lon, et al.
Mbio|May 16, 2019
Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human InfectionKathie-Anne Walters, Ruoqing Zhu, Michael Welge, et al.
Nature Communications|January 5, 2021
Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood samplingCarleen Klumpp-Thomas, Heather Kalish, Matthew Drew, et al.
Lancet (London, England)|June 15, 2020
Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trialJessica E Manning, Fabiano Oliveira, Iliano V Coutinho-Abreu, et al.
Science Translational Medicine|August 6, 2025
Nasal and systemic immune responses correlate with viral shedding after influenza challenge in people with complex preexisting immunityKathie-Anne Walters, Charles A Blatti, Ruoqing Zhu, et al.
Nature Medicine|July 1, 2020
Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge modelJae-Keun Park, Yongli Xiao, Mitchell D Ramuta, et al.
Science Translational Medicine|July 20, 2022
An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferretsJaekeun Park, Sharon L Fong Legaspi, Louis M Schwartzman, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|May 2, 2024
Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patientsAinhoa Pérez-Díez, Xiangdong Liu, Stephanie Calderon, et al.
Medrxiv : the Preprint Server for Health Sciences|October 6, 2021
Pre-pandemic SARS-CoV-2 serological reactivity in rural malaria-experienced CambodiansJessica Manning, Irfan Zaidi, Chanthap Lon, et al.
Science Translational Medicine|April 14, 2017
Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus diseaseJohn C Kash, Kathie-Anne Walters, Jason Kindrachuk, et al.
Emerging Infectious Diseases|January 25, 2022
SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, CambodiaJessica Manning, Irfan Zaidi, Chanthap Lon, et al.
Mbio|May 16, 2019
Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human InfectionKathie-Anne Walters, Ruoqing Zhu, Michael Welge, et al.
Nature Communications|January 5, 2021
Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood samplingCarleen Klumpp-Thomas, Heather Kalish, Matthew Drew, et al.
Lancet (London, England)|June 15, 2020
Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trialJessica E Manning, Fabiano Oliveira, Iliano V Coutinho-Abreu, et al.
Science Translational Medicine|August 6, 2025
Nasal and systemic immune responses correlate with viral shedding after influenza challenge in people with complex preexisting immunityKathie-Anne Walters, Charles A Blatti, Ruoqing Zhu, et al.
Nature Medicine|July 1, 2020
Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge modelJae-Keun Park, Yongli Xiao, Mitchell D Ramuta, et al.
Science Translational Medicine|July 20, 2022
An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferretsJaekeun Park, Sharon L Fong Legaspi, Louis M Schwartzman, et al.
Pageof 7